TL;DR

Statins can impair mitochondria (your cells’ energy engines)—shown in case reports, biopsies, lab work, animals, and newer human studies.
This helps explain fatigue, weakness, and poor exercise tolerance in some users..
In primary prevention (no known heart disease), absolute benefits are small over ~2–6 years: roughly 1 in 100–200 avoid a non-fatal MI; stroke and all-cause death change little. Benefits rise with higher baseline risk and in secondary prevention.
If you stay on a statin, monitor for mitochondrial-type symptoms (fatigue, muscle weakness and muscle pain) and consider mitochondrial support (training, nutrition; some clinicians trial CoQ10).
Do not stop a prescribed statin without talking to your clinician.

Cholesterol-lowering medications (statins) were first approved in 1987. Since 1995 there have been studies showing that statins can damage mitochondria—the parts of the cell that produce energy. The earliest signals (1995, 2002) were a case report and a small 4-patient crossover study [1,2]. Many other studies support these early findings [3,4,5,6], and newer human work does as well [7]. (There is more research than is shown here.)

We all know that statins interfere with the body’s production of CoQ10. That loss may be one reason mitochondria are affected. There’s also research showing mitochondrial impairment without a drop in muscle CoQ10, suggesting statins can harm mitochondria beyond CoQ10 depletion [8]. In fact, the literature shows several mechanisms of mitochondrial injury with statins [9].

Why this matters:

Statins can reduce your cells’ ability to make energy. That’s a big problem for tissues that burn a lot of energy—muscle in particular. These drugs can damage muscle cells—even when the damage isn’t severe enough to cause obvious pain. Your heart is muscle, and it’s fair to ask whether this physiology matters there, too. We can’t say statins “cause” heart failure; that hasn’t been proven—much like Semmelweis’ hand-washing wasn’t “proven” in the mid-19th century.

Statins were approved in 1987. Between 1990 and 2019, the global prevalence of heart failure surged by ~106%, reaching 56.2 million cases in 2019 [10]. This is not proof of causation—but the timing deserves attention.

Do statins do much to prevent heart attacks?

In people without known heart disease, the absolute benefits over ~2–6 years are small. Roughly:

About 1 in 100–200 people avoid a nonfatal heart attack over ~5 years.
All-cause death changes little; cardiovascular-death signals are inconsistent across trials.
Benefits are larger when baseline risk is higher and in secondary prevention (after an event).

If you choose to take a statin, watch for mitochondrial-type symptoms (fatigue, exercise intolerance) and consider supporting the “cell engines” (training, nutrition, magnesium; some clinicians trial CoQ10).
Do not stop a prescribed statin without talking to your clinician.

Big wins with bigger absolute benefits (and no mitochondrial downside): quit smoking, control blood pressure, walk daily, improve sleep, lower glycemic load, and address weight/insulin resistance.

FAQ

Q1) Do statins cause heart failure?
No proof of cause. But multiple human studies show mitochondrial damage in muscle on statins, so physiology concerns are reasonable to monitor.

Q2) If the benefits are small, why do guidelines recommend them?
Because a small relative benefit applied to large populations prevents events overall. For an individual, decide based on your risk and preferences.

Q3) Who is most likely to benefit?
People at higher risk (older age, high CAC score, multiple risk factors) and those in secondary prevention (past heart attack/stent). Low-risk adults often see tiny absolute gains.

Q4) What symptoms should I watch for?
New fatigue, exercise intolerance, muscle aches/weakness, or cramps. Report promptly.

Q5) Where does CoQ10 fit?
Statins can lower CoQ10. Trials for statin muscle symptoms are mixed; some show improvement, others don’t. A pragmatic trial is 200–300 mg/day with meals for 8–12 weeks while tracking symptoms. If you are on Warfarin, talk to your doctor first

Q6) I’m low risk. Should I skip statins entirely?
Discuss with your clinician.

Q7) What lifestyle changes have bigger absolute benefits?
Stop smoking, control blood pressure, walk daily, improve sleep, reduce glycemic load, manage weight/insulin resistance, and eat a Mediterranean-leaning diet.

Q8) If I stay on a statin, how can I protect mitochondria?
Prioritize aerobic + resistance training, nutrient-dense diet, adequate protein, possible CoQ10 trial, and ensure vitamin D/magnesium sufficiency.

Q9) Should I ever stop a statin?
Only with your prescriber. Options include dose reduction, alternate-day dosing, switching agents, or adding non-statin therapies—balanced against your personal risk.